H.C. Wainwright analysts reiterated a Buy rating on Axsome’s stock, maintaining a price target of $180, expressing confidence that no generic version will enter the U.S. market until at least 2040.

Herein, we disclose a transition-metal-free reaction system that enables α-cyanation of sulfonamides through C–H bond cleavage for the preparation of α-amino nitriles, including difficult-to-access ...

† Dalian Institute of Chemical Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian 116023, P. R. China ‡ University of Chinese Academy of Sciences, Beijing 100049, P. R. China § State Key ...